A significant insider transaction involving the exercise of company stock options was reported on November 12, by Nancy Ryan Gray, Director at Ligand Pharmaceuticals (NASDAQ:LGND), as per the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback